<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0002725'>Systemic lupus erythematosus</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) often appear concomitantly </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> and <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>-related ischemic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> cannot be distinguished clinically, although their etiology and treatment differ greatly </plain></SENT>
<SENT sid="2" pm="."><plain>Examination of a renal biopsy sample is therefore essential in order to provide the correct treatment </plain></SENT>
<SENT sid="3" pm="."><plain>We have observed that patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC), a serologic marker for APS, often have a <z:hpo ids='HP_0003010'>prolonged bleeding time</z:hpo>, which is a contraindication for performing a percutaneous renal biopsy </plain></SENT>
<SENT sid="4" pm="."><plain>We undertook this study to evaluate systematically the <z:mp ids='MP_0001914'>bleeding</z:mp> time in 27 consecutive patients </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: The <z:mp ids='MP_0001914'>bleeding</z:mp> time was measured in 27 patients who were persistently positive for LAC and who were not exposed to aspirin or <z:chebi fb="2" ids="35475">nonsteroidal antiinflammatory drugs</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Platelet function and <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) parameters were subsequently assessed in patients with a <z:hpo ids='HP_0003010'>prolonged bleeding time</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Twenty-one of 27 patients (78%) had a <z:hpo ids='HP_0003010'>prolonged bleeding time</z:hpo> despite a <z:mpath ids='MPATH_458'>normal</z:mpath> platelet count in the majority of patients (81%) </plain></SENT>
<SENT sid="8" pm="."><plain>Platelet functioning and vWF parameters in these 21 patients were <z:mpath ids='MPATH_458'>normal</z:mpath>, except for those in 1 patient with a mild storage pool disease </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: With this study, we introduce yet another paradox in the phenomenon of APS </plain></SENT>
<SENT sid="10" pm="."><plain>Although a <z:hpo ids='HP_0003010'>prolonged bleeding time</z:hpo> is generally accepted to be a sign of defective primary hemostasis, LAC is associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Further studies are needed to elucidate the mechanism behind this disturbance of primary hemostasis </plain></SENT>
</text></document>